FIELD: medicine.
SUBSTANCE: invention relates to medicine and can be used for treating ischemic cerebrovascular diseases. For this purpose water-soluble derivative of gamma-aminobutyric acid – 4-[(4-hydroxybenzoyl)amino]butyrate of lithium of formula
is applied.
EFFECT: invention provides cerebroprotective, nootropic and anxiolytic action, and it has low toxicity.
1 cl, 3 tbl, 2 dwg, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| POTASSIUM N-(4-ACETOXYBENZOYL)GLYCINATE POSSESSING CEREBROPROTECTIVE ACTIVITY | 2014 |
|
RU2556637C1 |
| BASIC MAGNESIUM SALT OF N-(4-ACETOXYBENZOYL)GLYCINE HAVING CEREBROPROTECTIVE ACTION | 2014 |
|
RU2570204C1 |
| DISODIUM SALT OF SALICYLURIC ACID, POSSESSING CEREBROPROTECTIVE ACTIVITY | 2014 |
|
RU2570644C1 |
| 4-(4-ACETOXYBENZOYLAMINO)BUTANOYLGLYCINE, WHICH HAS A CEREBROPROTECTIVE ACTION IN CEREBRAL ISCHEMIA | 2017 |
|
RU2657820C1 |
| DISODIUM SALT OF 3-HYDROXYHIPPURIC ACID, HAVING ANTIHYPOXIC AND CEREBROPROTECTIVE ACTION | 2014 |
|
RU2559875C1 |
| AGENT ELICITING ANTI-ISCHEMIC, HYPOTENSIVE, ANTI- -ARRHYTHMIC AND NOOTROPIC ACTIVITY | 2002 |
|
RU2216322C1 |
| AGENT POSSESSING NEUROPROTECTIVE ACTION IN ISCHEMIC CEREBRAL CIRCULATION DISORDER | 2015 |
|
RU2586301C1 |
| N-(ACETYLSALICYLOYL)PYRAZOL WITH CEREBROPROTECTOR ACTION IN CASE OF CEREBRAL CIRCULATION INSUFFICIENCY | 2016 |
|
RU2632005C1 |
| N-(4-ACETOXYBENZOYL)GLYCINE LITHIUM SALT POSSESSING TRANQUILISING AND NOOTROPIC ACTION | 2012 |
|
RU2505294C1 |
| AGENT POSSESSING CEREBRAL-PROTECTIVE, ENDOTHELIAL-POSITIVE AND ANTITHROMBOTIC EFFECT | 2015 |
|
RU2594254C1 |
